Home » Resources » Report from trial of topical rapamycin for angiofibromas

Report from trial of topical rapamycin for angiofibromas

Foster, R. S., Bint, L. J. and Halbert, A. R. (2012), Topical 0.1% rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: A pilot study of four patients. Australasian Journal of Dermatology, 53: 52–56. doi: 10.1111/j.1440-0960.2011.00837.x

This article reports on a small study in Western Australia using one of the mTOR inhibiting medicines in a cream that showed positive results in both reducing redness and bumpiness of angiofibromas.

Go to article in Wiley's online library